Clinical studies have demonstrated that Ozempic offers a substantial potential for weight lossoften surpassing other GLP-1 medications
Both liraglutide and semaglutide have received FDA approval for the treatment of T2DM, obesity, and cardiovascular risk reduction [ Table 2 ]
Zepbound improves insulin sensitivity by approximately 30%, which contributes to more stable blood sugar levels and reduced cravings
After 68 weeks of semaglutide injections, the average patient lost more than 15% of their body weight, but within 12 months of treatment ending, patients regained two thirds of their prior weight loss on average
Summary: Wegovy (semaglutide) and escitalopram (Cipralex) can generally be taken together safely, as no contraindication is listed in UK product information
Information on ongoing trials can be found via NIHR Be Part of Research (bepartofresearch.nihr.ac.uk), ClinicalTrials.gov , or the ISRCTN registry